CRS - CYTOKINE RELEASE SYNDROME
Clinical trials for CRS - CYTOKINE RELEASE SYNDROME explained in plain language.
Never miss a new study
Get alerted when new CRS - CYTOKINE RELEASE SYNDROME trials appear
Sign up with your email to follow new studies for CRS - CYTOKINE RELEASE SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Emergency rescue plan for cancer Treatment's dangerous side effects
Disease control Recruiting nowThis early-stage study is testing emergency rescue drugs for patients who develop severe, life-threatening immune reactions after receiving CAR-T cell cancer therapy. The study will enroll up to 10 adults already participating in CAR-T cell trials at the University of Pennsylvani…
Matched conditions: CRS - CYTOKINE RELEASE SYNDROME
Phase: EARLY_PHASE1 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC
-
Scientists hunt for early clues to stop deadly treatment reactions
Knowledge-focused Recruiting nowThis study aims to better predict which blood cancer patients are at high risk for dangerous side effects, like cytokine release syndrome (CRS), after receiving immunotherapy. Researchers will monitor 100 patients continuously with wireless sensors and blood tests to look for ear…
Matched conditions: CRS - CYTOKINE RELEASE SYNDROME
Phase: NA • Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated Apr 04, 2026 02:20 UTC